Generex licenses drug delivery tech for $10M; Evotec acquires Compound Focus in South San Francisco; PPD wins Army contract;

@FierceBiotech: Special Report: 5 emerging eClinical firms to watch. Report | Follow @FierceBiotech

@JohnCFierce: WSJ reports insider trading probe on SAC Capital and the MedImmune acquisition. Article | Follow @JohnCFierce

> Generex has licensed its RapidMist buccal (through the cheek) drug-delivery product to Sunnyvale, CA-based Amarantus BioSciences for $10 million. Story

> Evotec bought up Galapagos NV's South San Francisco-based Compound Focus, a compound management business, for 12.5 million euros. Evotec release

> The CRO PPD has won a $45.5 million, five-year contract to handle clinical trial services for the U.S. Army. PPD release

> AstraZeneca has won Canadian approval for its blockbuster heart drug Brilinta as it continues to jockey for a U.S. OK. Article

> Alexion Pharmaceuticals has won a priority review for Soliris-designed to treat a rare genetic disease--from the FDA. Item

> The US Army Medical Research and Material Command has awarded AcelRx a $5.6 million grant to support the development of a new product candidate, ARX-04, a sublingual product for moderate-to-severe acute pain. Release

> Germany's MediGene AG and The Johns Hopkins University agreed to collaborate in the field of AAVLP vaccine technology. Release

Pharma News

@FiercePharma: France to stop paying for Pfizer's Champix. News | Follow @FiercePharma

> Novartis scouts bolt-on deals of up to $3B. Report

> Novo plots China growth to protect market share. Article

> Pfizer, Teva settle long-running Neurontin fight. Story

Drug Delivery News

> MAP Pharma files NDA for orally inhaled migraine treatment. Item

> Fluorescent carbon nanotubes light the way for drug-delivery researchers. Story

> Generex licenses buccal delivery to Amarantus for $10M. Report

> Why we love and hate the blood-brain barrier. Piece

> 'Theragnostic' nanoparticle detects and treats tumors. Article

> Packaging RNA for long-lasting, nontoxic delivery. Item

Medical Device News

> Boston Sci recalls imaging catheters. News

> Shuren to appear before House panel this week. Story

> Neoprobe sells gamma detection biz to Devicor. Item

> Advance Medical raises $6M in Series A. Article

And Finally... After reviewing the literature the World Health Organization reports that cell phones just may trigger brain cancer. Report

Suggested Articles

Quench Bio is going after a family of proteins involved in inflammatory cell death to treat inflammatory diseases in a more holistic way.

What a difference a day makes in biotech.

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing.